Compare MLYS & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLYS | EVLV |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 994.7M |
| IPO Year | 2023 | 2020 |
| Metric | MLYS | EVLV |
|---|---|---|
| Price | $29.40 | $4.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $48.67 | $9.13 |
| AVG Volume (30 Days) | 997.6K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.43 | ★ 41.18 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $145,905,000.00 |
| Revenue This Year | N/A | $21.67 |
| Revenue Next Year | N/A | $19.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40.48 |
| 52 Week Low | $22.30 | $4.61 |
| 52 Week High | $47.65 | $8.81 |
| Indicator | MLYS | EVLV |
|---|---|---|
| Relative Strength Index (RSI) | 60.46 | 37.72 |
| Support Level | $25.34 | $4.87 |
| Resistance Level | $31.26 | $5.86 |
| Average True Range (ATR) | 1.40 | 0.17 |
| MACD | 0.49 | -0.03 |
| Stochastic Oscillator | 65.06 | 15.30 |
Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.
Evolv Technologies Holdings Inc is a security technology company pioneering Artificial Intelligence (AI)-powered screening solutions designed to help create safer environments while maintaining efficient visitor flow and a positive visitor experience. It serves customers across a range of end markets, including education, healthcare, sports, live entertainment, tourist attractions, houses of worship, and industrial workplaces. The company operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.